GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
2,455.05
-51.65 (-2.06%)
At close: Jul 17, 2026
BOM:500660 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, BOM:500660 stock has a consensus rating of "Buy" and an average price target of ₹2,970. The average 1-year stock price forecast is 20.96% higher than the current stock price, while the lowest is ₹2,600 (+5.90%) and the highest is ₹3,500 (+42.56%).
Price Target: ₹2,970 (+20.96%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for BOM:500660 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
41.94B
from 38.22B
Increased by 9.74%
Revenue Next Year
46.45B
from 41.94B
Increased by 10.76%
EPS This Year
67.98
from 60.11
Increased by 13.08%
EPS Next Year
77.28
from 67.98
Increased by 13.68%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.